An article titled “The global burden of pulmonary arterial hypertension: profound but improving?”, was published on October 18, 2024, on the The Lancet Respiratory Medicine. The authors are Joe Newman,Pulmonary Vascular Disease Unit, Royal Papworth Hospital, Cambridge, UK, Department of Medicine, University of Cambridge, Cambridge, UK and Joanna Pepke-Zaba, Pulmonary Vascular Disease Unit, Royal Papworth Hospital, Cambridge, UK, Department of Medicine, University of Cambridge, Cambridge, UK
The article refers to the variability in prevalence estimates for pulmonary arterial hypertension shown in the systematic review presented at the 7th World Symposium on Pulmonary Hypertension in Barcelona in June 2024. The authors say that the haemodynamic definition of PAH requires specialist right heart catheterisation infrastructure and skills, and this is likely contributing to regional differences in prevalence in line with economic factors. Refining PAH epidemiology is important, they add, in setting a threshold of diagnostic suspicion, understanding demographic groups most at risk, identifying emerging risk factors, and resource allocation.
The article is not open access. Read more at this link on The Lancet Respiratory Medicine
Citation
The global burden of pulmonary arterial hypertension: profound but improving?Newman, Joseph et al.The Lancet Respiratory Medicine, Volume 0, Issue 0
Photo credi: chuttersnap at Unsplash